AstraZeneca Shares Rise After Lung Drug Hits Goals in Late-Stage Trials
2 months ago
38
Tozorakimab met the superior extremity successful 2 late-stage objective trials, reducing the complaint astatine which patients’ symptoms worsened, the institution said.
2 months ago
38
.png)
